You just read:

Lexicon Pharmaceuticals Reports Additional Positive Data From Pivotal Phase 3 inTandem2 Study Of Sotagliflozin

News provided by

Lexicon Pharmaceuticals, Inc.

Aug 15, 2017, 07:00 ET